Efficacy of EGb761 120mg Bid Versus Placebo in Patients Suffering From Friedreich Ataxia. A 3 Month, Phase II, Randomised, Double Blind, Placebo Controlled, Parallel Group Clinical Study
Latest Information Update: 04 Apr 2022
At a glance
- Drugs EGb 761 (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- 21 Jun 2012 Company added in the association field as reported by ClinicalTrials.gov.
- 29 Nov 2011 Actual patient number is 22 according to ClinicalTrials.gov.
- 29 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.